Matches in SemOpenAlex for { <https://semopenalex.org/work/W2978074527> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2978074527 abstract "Abstract Introduction: Patients after relapsing allogeneic hematopoietic stem cell transplantation (AHSCT) have a treatment option of donor lymphocyte infusion (DLI). DLI is a form of adoptive immunotherapy which induces graft versus leukemia effect. Severe forms of graft versus host disease (GVHD) and marrow aplasia are known complications. In this study, we aimed to detect the effect of the infused CD3+ T cell dose on response, GVHD and overall survival (OS) of hematological malignancies after AHSCT. Methods: We retrospectively evaluated 78 DLI procedures in 57 patients with different hematological malignancies for relapse after AHSCT from June 2000 through June 2015. Initial DLI CD3+ cell dose/kg recipient body weight was ≤ 1x10^7 (n=20; Group 1), >1.0 to ≤ 5 x10^7 (n=29; Group 2), 5-10 x10^7 (n=29; Group 3). Chi-square test was used in comparison between groups. P<.05 was considered statistically significant. Results: The median age during DLI was 33,8 ± 13,2 (range 16-67 years) in 57 patients (38M/19F). The median time interval from HCT to DLI was 8.08 (2-69) months. Ten patients (18%) had bone marrow while 47 patients (82%) had peripheral blood as stem cell source. All patients received transplants from HLA-matched related siblings. There was no difference found between the three groups according to age, diagnosis, stem cell source and conditioning regimen. Achieving complete remission after DLI was detected in thirty two (56%) patients. Disease status after DLI, acute and chronic GVHD rates were not statistically different between the groups. Overall survival which was not statistically significant according to initial DLI cell dose at 2 years were 25%, 38% and 24%, respectively. Conclusion: An initial DLI CD3+ cell dose of 10 x10e7 or higher has been shown improve overall survival but increase GVHD rates with no effect on risk of relapse in previous reports. Response rate, GVHD and survival outcomes were found to be similar in comparison of three different DLI dose groups in our study. Disclosures No relevant conflicts of interest to declare." @default.
- W2978074527 created "2019-10-10" @default.
- W2978074527 creator A5006552750 @default.
- W2978074527 creator A5011716290 @default.
- W2978074527 creator A5030401832 @default.
- W2978074527 creator A5036379337 @default.
- W2978074527 creator A5038588053 @default.
- W2978074527 creator A5043084722 @default.
- W2978074527 creator A5065201669 @default.
- W2978074527 creator A5070704251 @default.
- W2978074527 creator A5076735212 @default.
- W2978074527 creator A5080776694 @default.
- W2978074527 creator A5081218567 @default.
- W2978074527 creator A5082785244 @default.
- W2978074527 creator A5085246270 @default.
- W2978074527 date "2015-12-03" @default.
- W2978074527 modified "2023-10-11" @default.
- W2978074527 title "Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?" @default.
- W2978074527 doi "https://doi.org/10.1182/blood.v126.23.5483.5483" @default.
- W2978074527 hasPublicationYear "2015" @default.
- W2978074527 type Work @default.
- W2978074527 sameAs 2978074527 @default.
- W2978074527 citedByCount "0" @default.
- W2978074527 crossrefType "journal-article" @default.
- W2978074527 hasAuthorship W2978074527A5006552750 @default.
- W2978074527 hasAuthorship W2978074527A5011716290 @default.
- W2978074527 hasAuthorship W2978074527A5030401832 @default.
- W2978074527 hasAuthorship W2978074527A5036379337 @default.
- W2978074527 hasAuthorship W2978074527A5038588053 @default.
- W2978074527 hasAuthorship W2978074527A5043084722 @default.
- W2978074527 hasAuthorship W2978074527A5065201669 @default.
- W2978074527 hasAuthorship W2978074527A5070704251 @default.
- W2978074527 hasAuthorship W2978074527A5076735212 @default.
- W2978074527 hasAuthorship W2978074527A5080776694 @default.
- W2978074527 hasAuthorship W2978074527A5081218567 @default.
- W2978074527 hasAuthorship W2978074527A5082785244 @default.
- W2978074527 hasAuthorship W2978074527A5085246270 @default.
- W2978074527 hasConcept C126322002 @default.
- W2978074527 hasConcept C141071460 @default.
- W2978074527 hasConcept C2777408962 @default.
- W2978074527 hasConcept C2778461978 @default.
- W2978074527 hasConcept C2779695342 @default.
- W2978074527 hasConcept C2779972918 @default.
- W2978074527 hasConcept C2780007613 @default.
- W2978074527 hasConcept C2781413609 @default.
- W2978074527 hasConcept C28328180 @default.
- W2978074527 hasConcept C2911091166 @default.
- W2978074527 hasConcept C54355233 @default.
- W2978074527 hasConcept C71924100 @default.
- W2978074527 hasConcept C86803240 @default.
- W2978074527 hasConcept C90924648 @default.
- W2978074527 hasConceptScore W2978074527C126322002 @default.
- W2978074527 hasConceptScore W2978074527C141071460 @default.
- W2978074527 hasConceptScore W2978074527C2777408962 @default.
- W2978074527 hasConceptScore W2978074527C2778461978 @default.
- W2978074527 hasConceptScore W2978074527C2779695342 @default.
- W2978074527 hasConceptScore W2978074527C2779972918 @default.
- W2978074527 hasConceptScore W2978074527C2780007613 @default.
- W2978074527 hasConceptScore W2978074527C2781413609 @default.
- W2978074527 hasConceptScore W2978074527C28328180 @default.
- W2978074527 hasConceptScore W2978074527C2911091166 @default.
- W2978074527 hasConceptScore W2978074527C54355233 @default.
- W2978074527 hasConceptScore W2978074527C71924100 @default.
- W2978074527 hasConceptScore W2978074527C86803240 @default.
- W2978074527 hasConceptScore W2978074527C90924648 @default.
- W2978074527 hasLocation W29780745271 @default.
- W2978074527 hasOpenAccess W2978074527 @default.
- W2978074527 hasPrimaryLocation W29780745271 @default.
- W2978074527 hasRelatedWork W2415072340 @default.
- W2978074527 hasRelatedWork W2471495776 @default.
- W2978074527 hasRelatedWork W2479521452 @default.
- W2978074527 hasRelatedWork W2482115402 @default.
- W2978074527 hasRelatedWork W2548848677 @default.
- W2978074527 hasRelatedWork W2550088330 @default.
- W2978074527 hasRelatedWork W2557035221 @default.
- W2978074527 hasRelatedWork W2558431434 @default.
- W2978074527 hasRelatedWork W2561980943 @default.
- W2978074527 hasRelatedWork W2561992355 @default.
- W2978074527 hasRelatedWork W2565051703 @default.
- W2978074527 hasRelatedWork W2582646460 @default.
- W2978074527 hasRelatedWork W2588359514 @default.
- W2978074527 hasRelatedWork W2755150613 @default.
- W2978074527 hasRelatedWork W2777860661 @default.
- W2978074527 hasRelatedWork W2914252651 @default.
- W2978074527 hasRelatedWork W2920797960 @default.
- W2978074527 hasRelatedWork W2979872004 @default.
- W2978074527 hasRelatedWork W2979905594 @default.
- W2978074527 hasRelatedWork W3047363175 @default.
- W2978074527 isParatext "false" @default.
- W2978074527 isRetracted "false" @default.
- W2978074527 magId "2978074527" @default.
- W2978074527 workType "article" @default.